Harold C Urschel

Summary

Publications

  1. ncbi Open-label study of a proprietary treatment program targeting type A gamma-aminobutyric acid receptor dysregulation in methamphetamine dependence
    Harold C Urschel
    The Urschel Recovery Science Institute, 8222 Douglas Ave, Suite 375, Dallas, TX 75225, USA
    Mayo Clin Proc 82:1170-8. 2007
  2. ncbi A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence
    Harold C Urschel
    Research Across America, CNS Research Group, Dallas, TX, USA
    J Psychopharmacol 25:254-62. 2011

Detail Information

Publications2

  1. ncbi Open-label study of a proprietary treatment program targeting type A gamma-aminobutyric acid receptor dysregulation in methamphetamine dependence
    Harold C Urschel
    The Urschel Recovery Science Institute, 8222 Douglas Ave, Suite 375, Dallas, TX 75225, USA
    Mayo Clin Proc 82:1170-8. 2007
    ....
  2. ncbi A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence
    Harold C Urschel
    Research Across America, CNS Research Group, Dallas, TX, USA
    J Psychopharmacol 25:254-62. 2011
    ..Decreased methylamphetamine use was also observed, as measured by urine drug screens and self-reports...